About
OncXerna Therapeutics is a clinical-stage precision medicine company utilizing an RNA-expression based biomarker platform to predict patient responses to targeted oncology therapies.
Explore OncXerna Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.